How Big Is the Emphysema Market | Insights & Growth 2025

Code: MTA5993 Publication Date: Jul 2025

How Big Is the Emphysema Market?

According to 6Wresearch internal database and industry insights,the Global Emphysema Market was valued at USD 4.1 Billion in 2024 and is expected to reach USD 5.6 Billion by 2031, expanding at a CAGR of 14.84%.

Key growth drivers include increasing prevalence of chronic obstructive pulmonary disease, rising geriatric population, and growing awareness about early diagnosis and pulmonary rehabilitation therapies.

Growth Factors of the Emphysema Market

  • Growing incidence of smoking-related respiratory illnesses globally.
  • Upsurge in aging population vulnerable to COPD-related disorders.
  • Advancements in lung volume reduction devices and non-surgical treatment options.
  • Surging demand for home-based respiratory therapy and portable oxygen devices.
  • Expansion of diagnostic facilities and spirometry-based screening.
  • Government support for pulmonary disease management programs.

Emphysema Market Trends

Emphysema Marketis witnessing notable shifts toward personalized medicine, with a growing preference for non-invasive treatments and biologics. The adoption of digital health tools like smart inhalers and remote monitoring is gaining traction. Moreover, pharmaceutical players are increasing R&D into regenerative therapies and novel bronchodilators aimed at improving lung function and slowing disease progression.

Emerging Developments in Emphysema Market

Emerging developments in the emphysema industry include the integration of AI-driven diagnostic tools to enhance early detection and disease staging. Innovative technologies such as bronchoscopic lung volume reduction and gene-targeted therapies are also in trial phases. Additionally, market players are collaborating with healthcare systems to develop hybrid models of care that combine hospital-based and at-home treatment services for emphysema patients.

Leading Companies in the Emphysema

  • Pulmonx Corporation
  • Olympus Corporation
  • Cipla Ltd.
  • Boehringer Ingelheim
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • AstraZeneca

How Big Is the Emphysema Market: FAQs

The drug therapy segment dominates due to its widespread adoption in symptom management.
Increasing awareness campaigns and integration of AI in radiology are improving diagnosis efficiency.
The market is expected to grow robustly due to rising COPD burden and advancements in minimally invasive treatment technologies.
Emphysema market is projected to surpass USD 5.6 Billion by 2031.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All